LUPRAC Side Effects

6177259-6 | Hepatic Function Abnormal
on Apr 23, 2009 Female patient from JAPAN , 66 years of age, was diagnosed with atrial septal defect, diabetes mellitus and was treated with Luprac (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Luprac dosage: . During the same period patient was treated with SILECE (View Silece Review and Silece Label ), AMARYL (View Amaryl Review and Amaryl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5840191-9 | Hypokalaemia, Pseudoaldosteronism
Patient was taking Luprac (View Usage). Patient had the following side effects: hypokalaemia, pseudoaldosteronism on Jul 29, 2008 from JAPAN Additional patient health information: Female patient , 79 years of age, . Luprac dosage: . During the same period patient was treated with TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ). Patient was hospitalized.

5819229-0 | Rhabdomyolysis
Adverse event was reported on Jul 15, 2008 by a Female patient taking Luprac (View Usage) (Dosage: ) was diagnosed with cardiac failure, anxiety (What is anxiety?), blood pressure increased and. Location: JAPAN , 81 years of age, After Luprac was administered, patient had the following side effects: rhabdomyolysis. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), MICARDIS (View Micardis Review and Micardis Label ), SIGMART (View Sigmart Review and Sigmart Label ). Patient was hospitalized.

5479514-1 | Intracardiac Thrombus
on Sep 27, 2007 Male patient from JAPAN , 41 years of age, was treated with Luprac (View Usage). Patient experienced the following unwanted or unexpected effects: intracardiac thrombus. Luprac dosage: Additional Indication: Cardiac Failure.. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), RENIVACE (View Renivace Review and Renivace Label ).


5455974-7 | Intracardiac Thrombus
on Sep 06, 2007 Male patient from JAPAN , 41 years of age, was treated with Luprac (View Usage). Patient had the following side effects: intracardiac thrombus. Luprac dosage: Additional Indication: Cardiac Failure.. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), RENIVACE (View Renivace Review and Renivace Label ).

5314899-8 | Toxic Skin Eruption
Patient was taking Luprac (View Usage). After Luprac was administered, patient had the following side effects: toxic skin eruption on Apr 25, 2007 from JAPAN Additional patient health information: Male patient , 66 years of age, . Luprac dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), BLOPRESS (View Blopress Review and Blopress Label ), PARIET (View Pariet Review and Pariet Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5269058-4 | Hepatic Function Abnormal
Adverse event was reported on Mar 12, 2007 by a Male patient taking Luprac (View Usage) (Dosage: ) was diagnosed with cardiac failure and. Location: JAPAN , 30 years of age, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. During the same period patient was treated with ACARDI (View Acardi Review and Acardi Label ), NEUQUINON (View Neuquinon Review and Neuquinon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), DIART (View Diart Review and Diart Label ), ASPENONE (View Aspenone Review and Aspenone Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TAKEPRON (View Takepron Review and Takepron Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5266299-7 | Vitamin B1 Deficiency
on Mar 09, 2007 Male patient from JAPAN , 66 years of age, was diagnosed with oedema and was treated with Luprac (View Usage). Patient had the following side effects: vitamin b1 deficiency. Luprac dosage: . During the same period patient was treated with PIRETANIDE (View Piretanide Review and Piretanide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ). Patient was hospitalized.

5255386-5 | Hepatic Function Abnormal
on Feb 26, 2007 Male patient from JAPAN , 30 years of age, was diagnosed with cardiac failure and was treated with Luprac (View Usage). After Luprac was administered, patient had the following side effects: hepatic function abnormal. Luprac dosage: . During the same period patient was treated with ACARDI (View Acardi Review and Acardi Label ), NEUQUINON (View Neuquinon Review and Neuquinon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), DIART (View Diart Review and Diart Label ), ASPENONE (View Aspenone Review and Aspenone Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TAKEPRON (View Takepron Review and Takepron Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5249254-2 | Vitamin B1 Deficiency
Patient was taking Luprac (View Usage). Patient experienced the following unwanted or unexpected effects: vitamin b1 deficiency on Feb 16, 2007 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with oedema and. Luprac dosage: . During the same period patient was treated with PIRETANIDE (View Piretanide Review and Piretanide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5241643-5 | Hepatic Function Abnormal
Adverse event was reported on Feb 09, 2007 by a Male patient taking Luprac (View Usage) (Dosage: ) was diagnosed with cardiac failure and. Location: JAPAN , 30 years of age, Patient had the following side effects: hepatic function abnormal. During the same period patient was treated with ACARDI (View Acardi Review and Acardi Label ), NEUQUINON (View Neuquinon Review and Neuquinon Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), DIART (View Diart Review and Diart Label ), ASPENONE (View Aspenone Review and Aspenone Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TAKEPRON (View Takepron Review and Takepron Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5228867-8 | Liver Disorder
on Jan 24, 2007 Male patient from JAPAN , 30 years of age, was diagnosed with cardiac failure and was treated with Luprac (View Usage). After Luprac was administered, patient had the following side effects: liver disorder. Luprac dosage: . Patient was hospitalized.

5228502-9 | Liver Disorder
on Jan 24, 2007 Male patient from JAPAN , 30 years of age, was diagnosed with cardiac failure and was treated with Luprac (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Luprac dosage: . Patient was hospitalized.

5190384-1 | Toxic Epidermal Necrolysis
Patient was taking Luprac (View Usage). Patient had the following side effects: toxic epidermal necrolysis on Sep 04, 2006 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with cardiac failure and. Luprac dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), LOCHOL (View Lochol Review and Lochol Label ), URINORM (View Urinorm Review and Urinorm Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALOSENN (View Alosenn Review and Alosenn Label ), PURSENNID (View Pursennid Review and Pursennid Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5156427-6 | Toxic Epidermal Necrolysis
Adverse event was reported on Sep 04, 2006 by a Female patient taking Luprac (View Usage) (Dosage: ) . Location: JAPAN , 67 years of age, After Luprac was administered, patient had the following side effects: toxic epidermal necrolysis. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), LOCHOL (View Lochol Review and Lochol Label ), URINORM (View Urinorm Review and Urinorm Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALOSENN (View Alosenn Review and Alosenn Label ), PURSENNID (View Pursennid Review and Pursennid Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5144170-9 | Toxic Epidermal Necrolysis
on Sep 04, 2006 Female patient from JAPAN , 67 years of age, was treated with Luprac (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Luprac dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), LOCHOL (View Lochol Review and Lochol Label ), URINORM (View Urinorm Review and Urinorm Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALOSENN (View Alosenn Review and Alosenn Label ), PURSENNID (View Pursennid Review and Pursennid Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5116702-8 | Oral Intake Reduced, Toxic Epidermal Necrolysis
on Sep 04, 2006 Female patient from JAPAN , 67 years of age, was treated with Luprac (View Usage). Patient had the following side effects: oral intake reduced, toxic epidermal necrolysis. Luprac dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), LOCHOL (View Lochol Review and Lochol Label ), URINORM (View Urinorm Review and Urinorm Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALOSENN (View Alosenn Review and Alosenn Label ), PURSENNID (View Pursennid Review and Pursennid Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5101238-0 | Aspiration, Cardiac Failure Congestive, Cardiomegaly, Coordination Abnormal, Depressed Level Of Consciousness, Pyrexia, Somnolence
Patient was taking Luprac (View Usage). After Luprac was administered, patient had the following side effects: aspiration, cardiac failure congestive, cardiomegaly, coordination abnormal, depressed level of consciousness, pyrexia, somnolence on Aug 31, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 89 years of age, was diagnosed with osteoporosis (What is osteoporosis?), hypertension, depression (What is depression?), memory impairment and. Luprac dosage: . During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), PAXIL (View Paxil Review and Paxil Label ), ARICEPT (View Aricept Review and Aricept Label ), BLOPRESS (View Blopress Review and Blopress Label ), ALFAROL (View Alfarol Review and Alfarol Label ). Patient was hospitalized.

5097208-1 | Agranulocytosis, Malaise, Sepsis
Adverse event was reported on Jun 21, 2006 by a Female patient taking Luprac (View Usage) (Dosage: ) was diagnosed with cardiac failure, acute myocardial infarction, hyperlipidaemia, hypertension, reflux oesophagitis and. Location: JAPAN , 81 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, malaise, sepsis (What is sepsis?). During the same period patient was treated with PANALDINE (View Panaldine Review and Panaldine Label ), LIPOVAS (View Lipovas Review and Lipovas Label ), BLOPRESS (View Blopress Review and Blopress Label ), TAKEPRON (View Takepron Review and Takepron Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), SIGMART (View Sigmart Review and Sigmart Label ), 8 HOUR BAYER (View 8-hour Bayer Review and 8-hour Bayer Label ). Patient was hospitalized.

4660568-7 | Leukopenia, Thrombocytopenia
on May 11, 2005 Female patient from , 80 years of age, was diagnosed with cardiac failure and was treated with Luprac (View Usage). Patient had the following side effects: leukopenia, thrombocytopenia. Luprac dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), AMLODIN (View Amlodin Review and Amlodin Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), GASTER (Reported As Gaster D.) (View Gaster Review and Gaster Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.